Digital Therapeutics Market to Cross USD 41.63 Billion by 2030 Driven by Rising Chronic Disease Burden and Increasing Emphasis on Patient-Centric Approach | Research by SNS Insider

According to SNS Insider, the digital therapeutics market is poised for remarkable growth driven by factors such as the burden of chronic diseases, technological innovations, patient-centric approaches, healthcare cost containment, regulatory support, and evolving consumer preferences.

Pune, Aug. 08, 2023 (GLOBE NEWSWIRE) -- “As per the SNS Insider report, the Digital Therapeutics Market, which was valued at approximately US$ 4.8 billion in 2022, is projected to attain a valuation of around US$ 41.63 billion by 2030. This growth is anticipated to occur at a Compound Annual Growth Rate (CAGR) of 31% throughout the forecast timeframe spanning from 2023 to 2030.”

Market Report Overview

Digital therapeutics, often abbreviated as DTx, is an innovative and rapidly evolving field within healthcare that leverages digital technologies to deliver evidence-based interventions aimed at preventing, managing, or treating various medical conditions. Unlike traditional pharmaceutical interventions, digital therapeutics harness the power of software applications, mobile devices, wearable sensors, and other digital tools to provide patients with personalized and interactive healthcare solutions. This emerging form of therapy holds immense promise in revolutionizing the way we approach healthcare by offering effective, convenient, and accessible treatments.

Market Analysis

In recent years, the healthcare industry has witnessed a significant paradigm shift with the advent of digital therapeutics, a novel approach that combines technology and medical interventions to deliver evidence-based therapeutic interventions to patients. This innovative field has captured the attention of healthcare providers, patients, and investors alike, propelling the digital therapeutics market onto a trajectory of robust growth. The global burden of chronic diseases such as diabetes, cardiovascular diseases, and mental health disorders has reached alarming levels. Digital therapeutics offer personalized, accessible, and scalable solutions for managing and preventing these conditions, thereby addressing a critical healthcare challenge. Advances in technology, including smartphones, wearable devices, and sensors, have paved the way for seamless integration of digital therapeutics into patients' daily lives.

Get a Sample Report of Digital Therapeutics Market@

Major Players Included in this Report are:

  • Welldoc, Inc
  • 2Morrow, Inc
  • Livongo Health, Inc. (Teladoc Health, Inc.)
  • Propeller Health (ResMed)
  • Fitbit LLC
  • Noom, Inc
  • Pear Therapeutics, Inc
  • Akili Interactive Labs, Inc. & Other Players

Impact of Recession on Digital Therapeutics Market Growth

The impact of a recession on the digital therapeutics market is complex and can result in both challenges and opportunities. Slower adoption rates, funding difficulties, regulatory delays, shifts in patient behavior, and healthcare provider budget constraints are potential hurdles. However, the focus on cost-effective solutions, chronic disease management, and telehealth integration could present avenues for growth even in challenging economic times.

Digital Therapeutics Market Report Scope:

Report Attributes Details
Market Size in 2022  US$ 4.8 Bn
Market Size by 2030  US$ 41.63 Bn
CAGR  CAGR of 31% From 2023 to 2030
Base Year  2022
Forecast Period  2023-2030
Historical Data  2020-2021
Digital Therapeutics Market: Key Segmentation • By Sales Channel (B2C, Patients, Caregivers, B28)
• By Application (Preventive Applications, Treatment/Care-related Applications)
Key Regional Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
Get an Excel-Data Sheet of Digital Therapeutics Market with Detailed Analysis (Sheet Included Market Size & Share of Regions, Countries and Continents Data)  Get Excel-Data Sheet

Impact of the Russia-Ukraine War

The Russia-Ukraine war has introduced a range of uncertainties and challenges that could influence the digital therapeutics market. Disruptions in supply chains, regulatory changes, data security concerns, and shifts in investment patterns are just a few of the potential impacts. To navigate these challenges, companies in the digital therapeutics sector need to remain adaptable, prioritize risk mitigation, and explore new strategies to ensure their products continue to contribute positively to healthcare despite the geopolitical landscape.

Do you have any specific queries or need any customization research on Digital Therapeutics Market, Enquiry Now@

Key Regional Developments

The digital therapeutics market's regional dynamics are multifaceted, shaped by factors such as technological advancement, regulatory frameworks, healthcare priorities, and economic conditions. As each region embraces digital therapeutics in its unique way, the global market is poised for exponential growth. However, it's important to note that challenges such as data privacy concerns, regulatory harmonization, and physician adoption need to be addressed for sustained and equitable market expansion across regions.

Key Takeaway from Digital Therapeutics Market Study

  • The B2B segment of the market focuses on providing tailored solutions for healthcare providers, payers, and organizations. Leveraging advanced technologies such as artificial intelligence, machine learning, and data analytics, B2B digital therapeutics platforms empower healthcare professionals to enhance patient outcomes, optimize treatment plans, and streamline care delivery.
  • The preventive applications segment within the market focuses on promoting wellness and preventing the onset of chronic diseases through technology-driven interventions. These solutions utilize a combination of behavior modification, lifestyle interventions, and education to empower individuals to make informed choices about their health.

Recent Developments Related to Digital Therapeutics Market

  • Big Health, a pioneering digital healthcare company, has recently announced its plans to acquire Limbix, a prominent developer of digital therapeutics focused on addressing teenage mental health challenges.
  • Tata Elxsi, a pioneering global technology and design company, has taken a significant step towards advancing the realm of digital therapeutics by joining the Digital Therapeutics Alliance.

Table of Contents

1. Introduction

2. Research Methodology

3. Market Dynamics

4. Impact Analysis

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. Digital Therapeutics Market Segmentation, By Sales Channel

9. Digital Therapeutics Market Segmentation, By Application

10. Regional Analysis

11. Company Profile

12. Competitive Landscape

13. USE Cases and Best Practices

14. Conclusion

Buy Single-User PDF of Digital Therapeutics Market Report@

[For more information or need any customization research mail us at]

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominate the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Access Complete Report Details@


Contact Data